Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells

Bibliografski detalji
Glavni autori:	Xue, L, Hardman, C, Chen, W, Batty, P, Ogg, G, Erpenbeck, V, Sandham, D
Format:	Conference item
Izdano:	American Thoracic Society 2018

Slični predmeti

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
od: Chen, W, i dr.
Izdano: (2018)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
od: Sandham, D, i dr.
Izdano: (2019)

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
od: Hardman, C, i dr.
Izdano: (2019)

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
od: Xue, L, i dr.
Izdano: (2019)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
od: Veit J. Erpenbeck, i dr.
Izdano: (2016-12-01)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
od: Ogg, G, i dr.
Izdano: (2015)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
od: Salimi, M, i dr.
Izdano: (2015)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
od: Xue, L, i dr.
Izdano: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
od: Xue, L, i dr.
Izdano: (2014)

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
od: Gonem, S, i dr.
Izdano: (2016)

The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
od: Christian Domingo, i dr.
Izdano: (2018-09-01)

Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma.
od: Christina Gress, i dr.
Izdano: (2024-01-01)

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
od: Luo, J, i dr.
Izdano: (2019)

Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
od: Hinks, T, i dr.
Izdano: (2017)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
od: Hardman, C, i dr.
Izdano: (2017)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
od: Hardman, CS, i dr.
Izdano: (2021)

Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases
od: Kazufumi Matsushita, i dr.
Izdano: (2015-07-01)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
od: Salimi, M, i dr.
Izdano: (2014)

Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.
od: Urs B Hagemann, i dr.
Izdano: (2014-01-01)

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism
od: Saunders, R, i dr.
Izdano: (2017)

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
od: Saunders, R, i dr.
Izdano: (2017)

Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
od: Salimi, M, i dr.
Izdano: (2017)

The roles of type 2 cytotoxic T cells in inflammation, tissue remodeling, and prostaglandin (PG) D2 production are attenuated by PGD2 receptor 2 antagonism
od: Chen, W, i dr.
Izdano: (2021)

Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.
od: Xue, L, i dr.
Izdano: (2012)

Prostaglandin E2 Inhibits Group 2 Innate Lymphoid Cell Activation and Allergic Airway Inflammation Through E-Prostanoid 4-Cyclic Adenosine Monophosphate Signaling
od: Yu Zhou, i dr.
Izdano: (2018-03-01)

Group 2 innate lymphoid cells and asthma
od: Hiroki Kabata, i dr.
Izdano: (2015-07-01)

Dendritic Cell Vaccines Impact the Type 2 Innate Lymphoid Cell Population and Their Cytokine Generation in Mice
od: Lily Chan, i dr.
Izdano: (2023-10-01)

Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
od: Armer, R, i dr.
Izdano: (2005)

Cytokine Networks between Innate Lymphoid Cells and Myeloid Cells
od: Arthur Mortha, i dr.
Izdano: (2018-02-01)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
od: Rojas Monica A, i dr.
Izdano: (2009-02-01)

Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis
od: Seungwon Ryu, i dr.
Izdano: (2020-03-01)

Group 2 Innate Lymphoid Cells in Allergic Rhinitis
od: Wang S, i dr.
Izdano: (2024-11-01)

Group 2 innate lymphoid cells and their surrounding environment
od: Maiko Naito, i dr.
Izdano: (2023-03-01)

Group 2 innate lymphoid cells in human asthma
od: Arifumi Iwata, i dr.
Izdano: (2023-04-01)

The Fate of Activated Group 2 Innate Lymphoid Cells
od: Laura Mathä, i dr.
Izdano: (2021-04-01)

Type 2 Innate Lymphoid Cells: Protectors in Type 2 Diabetes
od: Jacob D. Painter, i dr.
Izdano: (2021-08-01)

Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis
od: Xiaoqiang Wang, i dr.
Izdano: (2023-01-01)

Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs
od: Christophe Pellefigues, i dr.
Izdano: (2018-02-01)

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.
od: Salimi, M, i dr.
Izdano: (2013)

Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production.
od: Laura Mathä, i dr.
Izdano: (2019-01-01)